Health Topic

Understanding Insomnia: Causes, Symptoms, and Treatment Options

👤 Legit-Meds Editorial Team 🩹 Medically reviewed by: Clinical Pharmacist, PharmD 📅 Published: August 5, 2026 📅 Last reviewed: August 15, 2026

Legit-Meds Editorial Team Medically reviewed by Clinical Pharmacist, PharmD — August 2026

Insomnia is the most common sleep disorder, affecting approximately 30% of adults. It involves difficulty falling asleep, staying asleep, or waking too early and being unable to return to sleep. While occasional sleeplessness is normal, chronic insomnia can significantly impact health, mood, and daily functioning.

🏥 When to See a Doctor

Sleep difficulties occur at least 3 nights per week for 3+ months
Daytime impairment despite adequate sleep opportunity
Sleep problems significantly affect work, mood, or relationships
You suspect an underlying sleep disorder (sleep apnea, restless leg syndrome)
You are relying on sleep medications to fall asleep regularly

Types of Insomnia

Acute insomnia: Short-term, lasting days to weeks. Often triggered by stress, life changes, or environmental factors. Typically resolves without treatment.
Chronic insomnia: Occurs at least 3 nights per week for 3 months or longer. Causes significant daytime impairment. May require structured treatment.
Onset insomnia: Difficulty falling asleep at the beginning of the night.
Maintenance insomnia: Difficulty staying asleep, with frequent awakenings during the night.
Early morning awakening insomnia: Waking too early and being unable to return to sleep.

Causes and Risk Factors

Common Causes

Stress (work, financial, relationship)
Poor sleep habits and irregular schedules
Caffeine, alcohol, and nicotine use
Screen time before bed (blue light exposure)
Medications that disrupt sleep (stimulants, corticosteroids, some antidepressants)
Medical conditions (chronic pain, GERD, asthma, thyroid disorders)
Mental health conditions (anxiety, depression, PTSD)
Sleep disorders (sleep apnea, restless leg syndrome)
Jet lag and shift work

Sleep Hygiene

Good sleep hygiene practices form the foundation of insomnia treatment:

Consistent schedule: Go to bed and wake up at the same time every day, including weekends.
Sleep environment: Keep the bedroom cool (65–68°F), dark, and quiet. Use blackout curtains, white noise machines, or earplugs as needed.
Limit screen time: Avoid phones, tablets, and computers for at least 1 hour before bed. Blue light suppresses melatonin production.
Limit caffeine: Avoid caffeine after 2:00 PM (caffeine has a half-life of 5–6 hours).
Limit alcohol: While alcohol may help you fall asleep initially, it disrupts sleep architecture and causes fragmented sleep.
Exercise regularly: Regular physical activity promotes better sleep, but avoid vigorous exercise within 3 hours of bedtime.
Wind-down routine: Establish a relaxing pre-sleep routine (reading, warm bath, gentle stretching).
Limit naps: If you must nap, keep it to 20–30 minutes before 2:00 PM.

CBT-I: First-Line Treatment

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the recommended first-line treatment for chronic insomnia by the American Academy of Sleep Medicine (AASM) and the American College of Physicians.

CBT-I components include:

Sleep restriction: Limiting time in bed to actual sleep time, then gradually increasing.
Stimulus control: Using the bed only for sleep, getting out of bed if unable to sleep.
Cognitive restructuring: Changing unhelpful beliefs and attitudes about sleep.
Relaxation training: Progressive muscle relaxation, deep breathing, meditation.

CBT-I can be delivered in person, via telehealth, or through digital programs. It produces lasting improvements without the side effects or dependence risks of sleep medications.

Medication Options

Medications are generally recommended for short-term use and should be combined with behavioral treatments:

Melatonin receptor agonists: Ramelteon (Rozerem). Mimics natural melatonin. Minimal dependence risk.
Orexin receptor antagonists: Suvorexant (Belsomra), lemborexant (Dayvigo). Newer class that blocks wakefulness-promoting signals.
Non-benzodiazepine hypnotics ("Z-drugs"): Zolpidem (Ambien), eszopiclone (Lunesta), zaleplon (Sonata). Short-term use. Risk of dependence with prolonged use.
Benzodiazepines: Temazepam (Restoril), triazolam (Halcion). Effective but carry higher risk of dependence. Not recommended as first-line.
Antihistamines: Diphenhydramine (Benadryl), doxylamine (Unisom). Available OTC but may cause next-day drowsiness, tolerance develops quickly.
Over-the-counter melatonin: Supplements may help with circadian rhythm issues but evidence for general insomnia is mixed.

Resources

Sleep Foundation - Insomnia
AASM — American Academy of Sleep Medicine
NHLBI - Sleep Deprivation
CBT-I Provider Directory

Important: This guide is for educational purposes only. Insomnia may be a symptom of underlying medical or psychiatric conditions that require evaluation. Always consult your healthcare provider before starting sleep medications. In case of a medical emergency, call 911.

Questions and Answers

What is the difference between acute and chronic insomnia?

Acute insomnia is short-term, lasting days to weeks, often triggered by stress or life changes. Chronic insomnia occurs at least 3 nights per week for 3 months or longer and significantly impairs daytime functioning. Both types may benefit from sleep hygiene improvements, but chronic insomnia often requires structured treatment like CBT-I.

What is CBT-I?

Cognitive Behavioral Therapy for Insomnia (CBT-I) is the first-line recommended treatment for chronic insomnia. It is a structured program that helps identify and replace thoughts and behaviors that cause or worsen sleep problems. CBT-I includes components like sleep restriction, stimulus control, cognitive restructuring, and sleep hygiene education.

What medications are used for insomnia?

Options include melatonin receptor agonists (ramelteon), orexin receptor antagonists (suvorexant, lemborexant), non-benzodiazepine hypnotics (zolpidem, eszopiclone), benzodiazepines (for short-term use), and antihistamines (diphenhydramine, doxylamine). CBT-I is preferred over medications for long-term management.